1. Home
  2. DRD vs RLAY Comparison

DRD vs RLAY Comparison

Compare DRD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

HOLD

Current Price

$25.92

Market Cap

2.5B

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$13.50

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRD
RLAY
Founded
1895
2015
Country
South Africa
United States
Employees
3410
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DRD
RLAY
Price
$25.92
$13.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$32.63
$19.50
AVG Volume (30 Days)
234.3K
3.8M
Earning Date
08-19-2026
05-05-2026
Dividend Yield
2.24%
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
$39.23
N/A
Revenue Next Year
$30.12
$324.03
P/E Ratio
$15.32
N/A
Revenue Growth
N/A
53.44
52 Week Low
$13.08
$2.83
52 Week High
$39.37
$17.32

Technical Indicators

Market Signals
Indicator
DRD
RLAY
Relative Strength Index (RSI) 38.87 54.25
Support Level $23.26 $11.75
Resistance Level $30.99 $17.32
Average True Range (ATR) 1.06 0.94
MACD -0.22 0.01
Stochastic Oscillator 5.78 49.61

Price Performance

Historical Comparison
DRD
RLAY

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: